Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Nerges Winblad"'
Autor:
Fredrik Lanner, John P. Schell, Cheng Zhao, Nerges Winblad, Carmen Navarro, Banushree Kumar, Simon J. Elsässer
Publikováno v:
Nature Cell Biology
bioRxiv
bioRxiv pre
bioRxiv
bioRxiv pre
The first lineage choice made in human embryo development separates trophectoderm from the inner cell mass, which proceeds to form the pluripotent epiblast and primitive endoderm. Trophectoderm on the other hand gives rise to the placenta. Naïve plu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e1a09e425faac3eea857c049b9896dcf
Autor:
Sandra, Petrus-Reurer, Nerges, Winblad, Pankaj, Kumar, Laia, Gorchs, Michael, Chrobok, Arnika Kathleen, Wagner, Hammurabi, Bartuma, Emma, Lardner, Monica, Aronsson, Álvaro, Plaza Reyes, Helder, André, Evren, Alici, Helen, Kaipe, Anders, Kvanta, Fredrik, Lanner
Publikováno v:
Stem Cell Reports
Summary Human embryonic stem cell-derived retinal pigment epithelial (hESC-RPE) cells could serve as a replacement therapy in advanced stages of age-related macular degeneration. However, allogenic hESC-RPE transplants trigger immune rejection, suppo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::ff84bed2404c1a14ee393d065297709c
https://pubmed.ncbi.nlm.nih.gov/32197113
https://pubmed.ncbi.nlm.nih.gov/32197113
Autor:
Fredrik Lanner, Nerges Winblad
Publikováno v:
Nature. 548:398-400
The gene-editing technology CRISPR–Cas has been used in human embryos grown in vitro to correct a disease-associated mutation. The introduction of editing components at fertilization aided repair efficiency. See Article p.413 Genome editing could b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c3261a182f067157ffeb9168d20e544b
https://doi.org/10.1038/nature23533
https://doi.org/10.1038/nature23533
Autor:
Omar O. Abudayyeh, Konstantin Severinov, Jonathan S. Gootenberg, Nerges Winblad, John van der Oost, Wen Y Wu, David A. Scott, Matthias Heidenreich, Jeroen Kneppers, Sourav R Choudhury, Iana Fedorova, Feng Zhang, Ellen M DeGennaro, Prarthana Mohanraju, Bernd Zetsche
Publikováno v:
Nature biotechnology
Nat. Biotechnol. 35, 31–34 (2017); published online 5 December 2016; corrected after print 12 January 2017 In the version of this article initially published, in Fig. 2j, the percentage for the targets Mecp2, Nlgn3, and Drd1 should be 15.2%, not 16
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::10e69a6eda3e0da3bf8ed381f5a759a7
https://pubmed.ncbi.nlm.nih.gov/27918548
https://pubmed.ncbi.nlm.nih.gov/27918548
Autor:
Iana Fedorova, Jonathan S. Gootenberg, Nerges Winblad, Konstantin Severinov, John van der Oost, Omar O. Abudayyeh, David A. Scott, Feng Zhang, Matthias Heidenreich, Wen Y Wu, Jeroen Kneppers, Sourav R Choudhury, Ellen M DeGennaro, Prarthana Mohanraju, Bernd Zetsche
Microbial CRISPR-Cas defense systems have been adapted as a platform for genome editing applications built around the RNA-guided effector nucleases, such as Cas9. We recently reported the characterization of Cpf1, the effector nuclease of a novel typ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d6d8381e9b552fb1751ee7d27dea419c
